etomoxir has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
260 | 8 | 93 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grill, VE; Sako, Y | 1 |
1 other study(ies) available for etomoxir and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Dexamethasone; Epoxy Compounds; Fat Emulsions, Intravenous; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1990 |